scispace - formally typeset
G

Gernot Marx

Researcher at RWTH Aachen University

Publications -  323
Citations -  8497

Gernot Marx is an academic researcher from RWTH Aachen University. The author has contributed to research in topics: Intensive care & Medicine. The author has an hindex of 39, co-authored 280 publications receiving 6266 citations. Previous affiliations of Gernot Marx include University of Liverpool & University of Jena.

Papers
More filters
Journal ArticleDOI

Selenium blood concentrations in patients undergoing elective cardiac surgery and receiving perioperative sodium selenite.

TL;DR: Despite preemptive high-dose sodium-selenite administration, cardiac surgical patients experienced a significant decrease in circulating selenium levels on the first postoperative day, but was unable to improve the postoperative outcome in patients staying >1 d in ICU.
Journal ArticleDOI

Correction to: Incidence of severe sepsis and septic shock in German intensive care units: the prospective, multicentre INSEP study.

TL;DR: The members of the SepNet Critical Care Trials Group were provided in such a way that they could not be indexed as collaborators on PubMed and the publisher apologizes for this error.
Journal ArticleDOI

Perception of the 2020 SARS-CoV-2 pandemic among medical professionals in Germany: results from a nationwide online survey.

TL;DR: The perception of the COVID-19 pandemic among medical professionals in Germany is evaluated to indicate starting points on how medical professionals could be supported in carrying out their important activities during the ongoing and future healthcare challenges.
Journal ArticleDOI

Next-generation sequencing diagnostics of bacteremia in sepsis (Next GeneSiS-Trial): Study protocol of a prospective, observational, noninterventional, multicenter, clinical trial.

TL;DR: This prospective, observational, noninterventional, multicenter study for the first time investigates the performance as well as the clinical value of a NGS-based approach for the detection of bacteremia in patients with sepsis and may therefore be a pivotal step toward the clinical use of NGS in this indication.
Journal ArticleDOI

Multicenter, randomized, placebo-controlled phase III study of pyridoxalated hemoglobin polyoxyethylene in distributive shock (PHOENIX).

TL;DR: In this randomized, controlled phase III trial in patients with vasopressor-dependent distributive shock, administration of a pyridoxalated hemoglobin solution decreased the need for vasopressors but was associated with a trend to increased mortality.